Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain

David R. Burt; I. A.N. Creese; Solomon H. Snyder

doi:10.1126/science.847477

Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain

David R. Burt, I. A.N. Creese, Solomon H. Snyder

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Chronic treatment of rats with the neuroleptic drugs haloperidol, fluphenazine, and reserpine elicits a 20 to 25 percent increase in striatal dopamine receptor binding assayed with [³H)haloperidol. This increase in receptor sites may account for behavioral supersensitivity to dopamine receptor stimulants in such animals and for tardive dyskinesia in patients treated with these drugs.

Original language	English (US)
Pages (from-to)	326-328
Number of pages	3
Journal	Science
Volume	196
Issue number	4287
DOIs	https://doi.org/10.1126/science.847477
State	Published - 1977

ASJC Scopus subject areas

General

Access to Document

10.1126/science.847477

Cite this

@article{ee9c6bebb5ab44c4a146100496497904,

title = "Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain",

abstract = "Chronic treatment of rats with the neuroleptic drugs haloperidol, fluphenazine, and reserpine elicits a 20 to 25 percent increase in striatal dopamine receptor binding assayed with [3H)haloperidol. This increase in receptor sites may account for behavioral supersensitivity to dopamine receptor stimulants in such animals and for tardive dyskinesia in patients treated with these drugs.",

author = "Burt, {David R.} and Creese, {I. A.N.} and Snyder, {Solomon H.}",

year = "1977",

doi = "10.1126/science.847477",

language = "English (US)",

volume = "196",

pages = "326--328",

journal = "Science",

issn = "0036-8075",

publisher = "American Association for the Advancement of Science",

number = "4287",

}

TY - JOUR

T1 - Antischizophrenic drugs

T2 - Chronic treatment elevates dopamine receptor binding in brain

AU - Burt, David R.

AU - Creese, I. A.N.

AU - Snyder, Solomon H.

PY - 1977

Y1 - 1977

N2 - Chronic treatment of rats with the neuroleptic drugs haloperidol, fluphenazine, and reserpine elicits a 20 to 25 percent increase in striatal dopamine receptor binding assayed with [3H)haloperidol. This increase in receptor sites may account for behavioral supersensitivity to dopamine receptor stimulants in such animals and for tardive dyskinesia in patients treated with these drugs.

AB - Chronic treatment of rats with the neuroleptic drugs haloperidol, fluphenazine, and reserpine elicits a 20 to 25 percent increase in striatal dopamine receptor binding assayed with [3H)haloperidol. This increase in receptor sites may account for behavioral supersensitivity to dopamine receptor stimulants in such animals and for tardive dyskinesia in patients treated with these drugs.

UR - http://www.scopus.com/inward/record.url?scp=0017599705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017599705&partnerID=8YFLogxK

U2 - 10.1126/science.847477

DO - 10.1126/science.847477

M3 - Article

C2 - 847477

AN - SCOPUS:0017599705

VL - 196

SP - 326

EP - 328

JO - Science

JF - Science

SN - 0036-8075

IS - 4287

ER -

Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this